[HTML][HTML] Recommendations on screening for prostate cancer with the prostate-specific antigen test

N Bell, SC Gorber, A Shane, M Joffres, H Singh… - Cmaj, 2014 - Can Med Assoc
Methods The Canadian Task Force on Preventive Health Care is an independent panel of
volunteer clinicians and methodologists that makes recommendations about clinical …

[HTML][HTML] Prostate cancer screening: Canadian guidelines 2011

JI Izawa, L Klotz, DR Siemens, W Kassouf… - Canadian Urological …, 2011 - ncbi.nlm.nih.gov
A systematic literature search was conducted in the following electronic bibliographic
databases: MEDLINE, including PreMedline (2004 to November 2010), EMBASE (2004 to …

Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians

A Qaseem, MJ Barry, TD Denberg… - Annals of internal …, 2013 - acpjournals.org
Chinese translation Description: Prostate cancer is an important health problem in men. It
rarely causes death in men younger than 50 years; most deaths associated with it occur in …

Prostate-specific antigen test use reported in the 2000 National Health Interview Survey

LE Ross, RJ Coates, N Breen, RJ Uhler, AL Potosky… - Preventive …, 2004 - Elsevier
Background. In 2000, the National Health Interview Survey (NHIS) collected information
about prostate-specific antigen (PSA) test use in a representative sample of US men …

[HTML][HTML] Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review

S Carlsson, AJ Vickers, M Roobol… - Journal of Clinical …, 2012 - ncbi.nlm.nih.gov
Recently, the US Preventive Services Task Force (USPSTF) published a review of the
evidence for screening for prostate cancer1 and made a clear recommendation against …

Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary …

G Trottier, MJ Roobol, N Lawrentschuk… - BJU …, 2011 - Wiley Online Library
Study Type–Prognosis (inception cohort) Level of Evidence 1b OBJECTIVE• To compare the
Prostate Cancer Prevention Trial Risk Calculator (PCPT‐RC) and European Randomized …

Screening for prostate cancer: recommendation and rationale

US Preventive Services Task Force* - Annals of Internal Medicine, 2002 - acpjournals.org
This statement summarizes the current US Preventive Services Task Force (USPSTF)
recommendations on screening for prostate cancer and updates the 1996 recommendations …

[PDF][PDF] Screening for prostate cancer: the current evidence and guidelines controversy

LG Gomella, XS Liu, EJ Trabulsi… - Canadian Journal of …, 2011 - researchgate.net
Task Force (USPSTF) states that evidence is insufficient to assess the risks and benefits of
prostate cancer screening in men younger than 75 years. Other major international health …

[HTML][HTML] Canadian Urological Association recommendations on prostate cancer screening and early diagnosis

RA Rendon, RJ Mason, K Marzouk… - Canadian Urological …, 2017 - ncbi.nlm.nih.gov
Prostate cancer remains the most commonly diagnosed noncutaneous malignancy among
Canadian men and is the third leading cause of cancer-related death. In 2016, an estimated …

[HTML][HTML] Prostate-specific antigen-based screening for prostate cancer: an evidence update for the US Preventive Services Task Force

K Lin, JM Croswell, H Koenig, C Lam, A Maltz - 2011 - europepmc.org
Background In 2008, the US Preventive Services Task Force (USPSTF) concluded that the
evidence was insufficient to assess the balance of benefits and harms of screening for …